Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price traded down 6.1% on Tuesday after an insider sold shares in the company. The company traded as low as $16.65 and last traded at $16.8450. 448,966 shares traded hands during trading, a decline of 1% from the average session volume of 454,036 shares. The stock […]

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report)’s stock price was down 6.1% during trading on Tuesday following insider selling activity. The stock traded as low as $16.65 and last traded at $16.8450. Approximately 448,966 shares traded hands during mid-day trading, a decline of 1% from the average daily volume of 454,036 shares. The stock […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) insider Jeffrey Alan Jones sold 4,632 shares of the company’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $9.67, for a total transaction of $44,791.44. Following the sale, the insider directly owned 169,532 shares of the company’s stock, […]

Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report) Director Peter Thompson sold 875 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $44.49, for a total value of $38,928.75. Following the completion of the transaction, the director owned 3,595,011 shares of the company’s stock, […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) insider Jennifer Michaelson sold 2,898 shares of the business’s stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $9.67, for a total value of $28,023.66. Following the transaction, the insider directly owned 133,980 shares in the company, […]

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) insider Jennifer Michaelson sold 2,148 shares of Cullinan Therapeutics stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $12.38, for a total transaction of $26,592.24. Following the completion of the sale, the insider owned 137,873 shares in the company, […]